Abstract:Antimicrobial peptides (AMPs) have aroused extensive attention due to their low incidences of resistance, yet their clinical transformation is thwarted by inferior selectivity and metabolic stability concerns, manifesting as rapid degradation, off‐target, and non‐selective toxicity. Here, a captivating affinity‐filtering strategy is proposed as a feasible solution for such challenges. Specifically, based on the selective affinity of AMPs toward distinct phospholipids, the membrane of host cells (e.g., erythrocytes) is pre‐bound to AMPs as the “filter,” which could screen out off‐target substances with non‐specific affinity while maintaining effective interaction with high‐affinity pathogens through competitive binding, realizing precise targeting, and enhanced stability. The practicability of the affinity‐filtering strategy has been demonstrated both in vitro and in vivo, through systematic studies on various AMPs and AMPs‐modified delivery systems with multiple fungal infection models (Candida albicans and Cryptococcus neoformans), which pose severe threats to human health worldwide yet are often neglected. AMP‐modified nanoparticles with affinity filtering exhibit reduced off‐target toxicity, sufficient binding with target pathogen, as well as a substantially elevated 21‐day survival rate from 30% (conventional drug‐loaded nanoparticles) to 70%. In summary, this strategy may provide inspiration for overcoming off‐target effects in drug targeting and further promote the clinical application of AMPs. An affinity‐filtering strategy for augmenting the targeting of antimicrobial peptides (AMPs) is developed through using erythrocytes to pre‐bind AMPs with relatively weak affinity and amplified to targeted drug delivery. The complex remains relatively stable when encountering similar affinity in vivo, and could readily dissociate and re‐bind to pathogens, in a precisely targeted manner, thus avoiding off‐target effect in drug delivery.

Phage‐displayed Heptapeptide Sequence Conjugation Significantly Improves the Specific Targeting Ability of Antimicrobial Peptides Against Staphylococcus Aureus

Hybrid Antimicrobial Peptide Targeting<i>Staphylococcus aureu</i>s and Displaying Anti-infective Activity in a Murine Model

Specifically Targeted Antimicrobial Peptides Synergize with Bacterial-Entrapping Peptide Against Systemic MRSA Infections.

Fluorimetric Sandwich Affinity Assay for Staphylococcus Aureus Based on Dual-Peptide Recognition on Magnetic Nanoparticles

Repurposing a drug targeting peptide for targeting antimicrobial peptides against Staphylococcus

An Engineered Multidomain Bactericidal Peptide As a Model for Targeted Antibiotics Against Specific Bacteria

Targeted and Intracellular Antibacterial Activity against S. agalactiae of the Chimeric Peptides Based on Pheromone and Cell-Penetrating Peptides

Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant <i>Staphylococcus aureus</i>

Bactericidal Efficiency and Mechanism of Specifically Targeted Antimicrobial Peptides Optimized Based on Structural and Functional Relationships

Overcoming Planktonic and Intracellular Staphylococcus Aureus-Associated Infection with a Cell-Penetrating Peptide-Conjugated Antimicrobial Peptide

Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.

Bactericidal Peptide Targeted Against Penicillin/Methicillin-resistant Staphylococcus Aureus--an Engineered Multidomain Protein Machine

Enhanced Cell Selectivity of Hybrid Peptides with Potential Antimicrobial Activity and Immunomodulatory Effect.

Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

Enhancement of Antimicrobial Function by L/D-Lysine Substitution on a Novel Broad-Spectrum Antimicrobial Peptide, Phylloseptin-TO2: A Structure-Related Activity Research Study

A Novel Peptide Screened by Phage Display Can Mimic TRAP Antigen Epitope Against Staphylococcus Aureus Infections

Development of a Novel Antibacterial Peptide, PAM-5, via Combination of Phage Display Selection and Computer-Assisted Modification

Potential Therapeutic Efficacy of a Bactericidal–immunomodulatory Fusion Peptide Against Methicillin-Resistant Staphylococcus Aureus Skin Infection

Fatty Acid Chain Modification Enhances the Serum Stability of Antimicrobial Peptide B1 and Activities Against Staphylococcus Aureus and Klebsiella Pneumoniae

Two Optimized Antimicrobial Peptides with Therapeutic Potential for Clinical Antibiotic-Resistant Staphylococcus Aureus.

Augmenting the Precise Targeting of Antimicrobial Peptides (AMPs) and AMP‐Based Drug Delivery via Affinity‐Filtering Strategy